这些数据不全面。M疫苗对重病防护100%，详见内

https://www.nih.gov/news-events/news-releases/peer-reviewed-report-moderna-covid-19-vaccine-publishes

From the start of the trial through Nov. 25, 2020, investigators recorded 196 cases of symptomatic COVID-19 occurring among participants at least 14 days after they received their second shot. One hundred and eighty-five cases (30 of which were classified as severe COVID-19) occurred in the placebo group and 11 cases (0 of which were classified as severe COVID-19) occurred in the group receiving mRNA-1273. The incidence of symptomatic COVID-19 was 94.1% lower in those participants who received mRNA-1273 as compared to those receiving placebo.

 

 

这可是来自NIH的官网。

杜编可以安心了，

所有跟帖： 

• 多谢！ -dudaan- ♂ (0 bytes) () 03/23/2021 postreply 07:22:13